NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/17/2026
Back to search
Official data from USPTO
PHARMACORD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMACORD
ST13
US500000087236919Class
35, 36, 41, 42, 44, 45
Filing
87236919
Registration
5782112
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
03/18/2026
Trademark type
Word
Nice classes
35, 36, 41, 42, 44, 45
Filing date
11/15/2016
Registration date
06/18/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2026
Last transaction
03/18/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/01/2018
First use in commerce
10/01/2018
Drawing code
4
Owner type
16
Owner location
Louisville, KY, US
Examiner
COGAN, BRITTNEY LORRAINE
Current location
Historical data usage
Holders and representatives
Holders
PharmaCord LLC
Representatives
Trevor T. Graves STITES & HARBISON PLLC
Technical classification
Nice Classes
Class 35Class 36Class 41Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Market analysis services in the field of specialty drug commercialization; Business consulting services relating to product distribution and operations management in the field of new specialty drugs; Patient relationship management services; Business consulting services relating to the operation of quick start and interim care programs; Management services provided to pharmaceutical manufacturers for controlling drug inventories; Healthcare business administration servicesadministering patient reimbursement programs and administering pharmacy reimbursement programs; Business management in the field of patient assistance programsprescription drugs and new specialty drugs
Class 36
Claims administration services in the field of health insuranceadministration and coordination of healthcare assignment of benefits for others and verification of patient eligibility for health- and prescription-benefits coverage of pharmaceuticals; Financial administration of patient reimbursement programs; Financial management of reimbursement payments for others
Class 41
Educational servicesconducting programs in the fields of drug therapyside effect managementlifestyle managementdisease state management and proper administration of medication; Educational servicesproviding clinical support programs regarding drug therapyside effect managementdisease state management and proper administration of medication
Class 42
Data warehousing services; Database development servicescollecting and maintaining patient information and registry data; Database development servicescustomized data collection and maintaining related databases in the field of prescription drugs; Software as a service (SAAS) serviceshosting software for use by others for the purpose of connecting clinical programs with specialty drug manufacturersmanaging inventorybilling and account receivablesas well as shipping and reportingmaster patient data aggregation and analysiscall center services; Developing customized software for others for the purpose of connecting clinical programs with specialty drug manufacturersmanaging inventorybilling and account receivablesas well as managing shipping and reportingmaster patient data aggregation and analysiscall center services
Class 44
Medical counseling in the field of drug therapyside effect managementdisease state management and proper administration of medication; Pharmaceutical consultation in the field of new specialty drugs; Providing information to patients in the field of administering medications; Providing medical information to patients; Patient health care counseling and advice regarding products in the field of prescription drugs; Providing information in the field of prescription drugs distributed via the Internet
Class 45
Personal lifestyle consulting services; Providing patient advocate and case management servicescoordinating the procurement and administration of medication; Providing emotional counseling and emotional support services for medical patients
Publications
History of USPTO decisions and trademark events.
58 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/17/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/17/2026
E815
TEAS SECTION 8 & 15 RECEIVED
12/15/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/19/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/19/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/19/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/19/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/10/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/10/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/10/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/18/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/14/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/13/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/30/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/29/2019
EX3G
SOU EXTENSION 3 GRANTED
04/29/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/29/2019
IUAF
USE AMENDMENT FILED
04/23/2019
EXT3
SOU EXTENSION 3 FILED
04/23/2019
EEXT
SOU TEAS EXTENSION RECEIVED
04/23/2019
EISU
TEAS STATEMENT OF USE RECEIVED
04/23/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/25/2018
EX2G
SOU EXTENSION 2 GRANTED
10/23/2018
EXT2
SOU EXTENSION 2 FILED
10/23/2018
EEXT
SOU TEAS EXTENSION RECEIVED
10/23/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/26/2018
EX1G
SOU EXTENSION 1 GRANTED
04/24/2018
EXT1
SOU EXTENSION 1 FILED
04/24/2018
EEXT
SOU TEAS EXTENSION RECEIVED
04/24/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/24/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/29/2017
PUBO
PUBLISHED FOR OPPOSITION
08/29/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/21/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
07/21/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/21/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
07/21/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/21/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/05/2017
GNFR
FINAL REFUSAL E-MAILED
07/05/2017
CNFR
FINAL REFUSAL WRITTEN
07/05/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/16/2017
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/16/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/15/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/15/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/22/2017
GNRT
NON-FINAL ACTION E-MAILED
02/22/2017
CNRT
NON-FINAL ACTION WRITTEN
02/22/2017
DOCK
ASSIGNED TO EXAMINER
02/22/2017
MPMK
NOTICE OF PSEUDO MARK E-MAILED
11/22/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/21/2016
NWAP
NEW APPLICATION ENTERED
11/18/2016
Continuous trademark protection
Get notified about every new filing that threatens PHARMACORD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.